证券代码：002674 证券简称：兴业科技 公告编号：2025-069 兴业皮革科技股份有限公司 关于为子公司提供担保的进展公告（七） 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 兴业皮革科技股份有限公司（以下简称"公司"）于 2025 年 4 月 24 日召开第 六届董事会第十次会议，会议审议通过了《关于公司为子公司提供担保额度的议 案》，该议案于 2025 年 5 月 19 日经公司 2024 年度股东大会审议通过。公司向下 属子公司提供累计不超过 14.3 亿元的新增担保额度，其中为子公司福建宝泰皮 革有限公司（以下简称"宝泰皮革"）提供担保额度 40,000 万元，为子公司宏兴 汽车皮革（福建）发展有限公司（以下简称"宏兴汽车皮革"）提供担保额度 52,000 万元，上述担保额度的有效期为自股东大会审议通过之日起 12 个月内。上述具 体内容详见公司于 2025 年 4 月 26 日在《证券时报》《证券日报》及巨潮资讯网 （www.cninfo.com.cn）披露的《兴业皮革科技股份有限公司关于为子公司提供担 保额度的公告》（2025-019）。 ...

Core Viewpoint - The company has approved a proposal to provide a cumulative guarantee limit of up to 1.43 billion yuan for its subsidiaries, indicating a strategic move to support its business operations and financial stability [1] Summary by Relevant Sections - **Guarantee Amounts** The company has approved a total guarantee limit of 1.43 billion yuan for its subsidiaries, with specific guarantees already issued: 50 million yuan to Baotai Leather and 40 million yuan to Hongxing Automotive Leather [1] - **Current Guarantee Status** As of now, the company's total external guarantee amount stands at 1.18 billion yuan, which represents 49.04% of the audited net assets attributable to the listed company for the year 2024 and 26.28% of the total assets [1] - **No Overdue Guarantees** The company reports that there are no overdue guarantees, reflecting a stable financial position regarding its commitments [1]

Investment Rating - The report maintains a "Buy" rating for the company [6] Core Views - In the short term, the company's performance is expected to be under pressure, but there is potential for recovery in 2026 due to the release of overseas production capacity and growth in automotive leather demand [2][10] - The company has entered the supply chains of global sports brands like Adidas and VF, which could open up growth and valuation opportunities in the long term [2][10] - New businesses such as Hongxing and Baotai are in a high growth phase, driven by platform advantages and a favorable industry environment, contributing to the company's expected growth [2][10] Financial Summary - For the first three quarters of 2025, the company achieved revenue of 2.01 billion yuan, a slight increase of 0.01% year-on-year, but the net profit attributable to the parent company decreased by 64% to 40 million yuan [4][10] - In Q3 2025, the company reported revenue of 670 million yuan, a decrease of 10% year-on-year, with net profit attributable to the parent company dropping by 84% to 8 million yuan [4][10] - The projected net profits for 2025 to 2027 are 80 million yuan, 130 million yuan, and 150 million yuan, respectively, with year-on-year changes of -44%, +62%, and +15% [2][10]

Market Overview - The textile manufacturing sector increased by 1.38% compared to the previous trading day, with Furui Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 4000.14, down 0.07%, while the Shenzhen Component Index closed at 13240.62, down 0.36% [1] Stock Performance - Notable gainers in the textile manufacturing sector included: - Chuiru Co., Ltd. (002083) with a closing price of 9.55, up 10.02% with a trading volume of 2.7871 million shares and a turnover of 249.5 million yuan [1] - Lianfa Co., Ltd. (002394) closed at 12.74, up 5.46% with a trading volume of 287,800 shares and a turnover of 26.5 million yuan [1] - Weixing Co., Ltd. (002003) closed at 11.84, up 5.06% with a trading volume of 217,500 shares and a turnover of 255 million yuan [1] Capital Flow - The textile manufacturing sector experienced a net outflow of 149 million yuan from institutional investors, while retail investors saw a net inflow of 139 million yuan [2] - The sector's overall capital flow indicates a mixed sentiment, with institutional investors withdrawing funds while retail investors increased their positions [2] Individual Stock Capital Flow - Lianfa Co., Ltd. (002394) had a net inflow of 17.9081 million yuan from institutional investors, while retail investors had a net outflow of 32.9972 million yuan [3] - Weixing Co., Ltd. (002003) saw a net inflow of 7.1284 million yuan from institutional investors, with retail investors experiencing a net inflow of 2.9226 million yuan [3] - Other notable stocks included: - Taihua New Materials (603055) with a net inflow of 7.2401 million yuan from institutional investors [3] - Luta A (000726) with a net inflow of 1.1835 million yuan from institutional investors [3]

证券代码：002674 证券简称：兴业科技 公告编号：2025-068 兴业皮革科技股份有限公司 关于为子公司提供担保的进展公告（六） 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 兴业皮革科技股份有限公司（以下简称"公司"）于 2025 年 4 月 24 日召开第 六届董事会第十次会议，会议审议通过了《关于公司为子公司提供担保额度的议 案》，该议案于 2025 年 5 月 19 日经公司 2024 年度股东大会审议通过。公司向下 属子公司提供累计不超过 14.3 亿元的新增担保额度，其中为子公司福建宝泰皮 革有限公司（以下简称"宝泰皮革"）提供担保额度 40,000 万元，上述担保额度 的有效期为自股东大会审议通过之日起 12 个月内。上述具体内容详见公司于 2025 年 4 月 26 日在《证券时报》《证券日报》及巨潮资讯网（www.cninfo.com.cn） 披露的《兴业皮革科技股份有限公司关于为子公司提供担保额度的公告》 （2025-019）。 一、担保情况概述 招商银行股份有限公司泉州分行（以下简称"招商银行泉州分行"）批准向 子公司宝泰皮革提供 ...

Core Viewpoint - The company Xinyi Technology (002674.SZ) has confirmed that its subsidiary, Hongxing Automotive Leather, supplies interior leather to various automotive brands, including Zun Jie, NIO, and Ideal, but has not yet established a business relationship with XPeng Motors [1] Group 1 - The subsidiary Hongxing Automotive Leather is a supplier of interior leather for multiple automotive brands [1] - Current clients include Zun Jie, NIO, and Ideal [1] - No existing business cooperation with XPeng Motors [1]

Core Viewpoint - The major shareholder of Xingye Technology (002674.SZ), Fujian Chunhong Equity Investment Partnership, plans to reduce its stake by up to 8,866,500 shares, representing 3% of the total share capital, over the next three months, which may raise approximately 126 million yuan based on the current share price [1]. Shareholding Structure - Fujian Wanjing Equity Investment Partnership holds 28.67% of the shares, amounting to 84,744,000 shares, with 41,696,000 shares pledged [2]. - Wu Guoshi, an individual shareholder, owns 13.42% of the shares, totaling 39,666,886 shares, with 18,600,000 shares pledged [2]. - Fujian Chunhong Equity Investment Partnership holds 10.65% of the shares, equating to 31,464,000 shares [2]. Financial Performance - For the first three quarters of 2025, the company reported revenue of 2.014 billion yuan, a slight increase of 0.01% year-on-year, while net profit attributable to shareholders decreased by 63.86% to 39.66 million yuan [2]. - The net cash flow from operating activities increased by 60.64% to 273 million yuan [2]. - In 2024, the company achieved revenue of 2.951 billion yuan, a year-on-year growth of 9.32%, but net profit decreased by 23.97% to 141.64 million yuan [4].

Group 1 - Huayang Intelligent's shareholder, Fosun Weiying, plans to reduce its stake by up to 285.42 million shares, representing no more than 5% of the company [1] - Kangtai Biological's controlling shareholder's concerted actor, Du Xinglian, intends to reduce its stake by up to 272.4 million shares, which is no more than 0.24% of the total share capital [2] - Mindray Medical has submitted an application for H-share issuance and listing on the Hong Kong Stock Exchange [4] Group 2 - Junpu Intelligent's chairman, Liu Yuan, resigned for personal reasons, and Wang Jianfeng was elected as the new chairman [6] - Mingchen Health's actual controller and executives plan to collectively reduce their stake by up to 8.61 million shares, accounting for 3.27% of the total share capital [7] - Zhongheng Design's directors and executives plan to reduce their stake by up to 151.57 million shares, representing no more than 0.55% of the total share capital [9] Group 3 - ST Erya and its actual controller, Zheng Jiping, are still under investigation by the China Securities Regulatory Commission [10] - Qicai Chemical's shareholder, Beijing Fengyan, plans to reduce its stake by up to 399.12 million shares, accounting for 0.98% of the total share capital [11] - Aier Eye Hospital plans to distribute a cash dividend of 0.8 yuan per 10 shares to all shareholders, totaling approximately 744 million yuan [12] Group 4 - Meiri Interactive's actual controller's concerted actor plans to reduce its stake by up to 394.74 million shares, which is 1% of the total share capital [13] - Maipu Medical's pre-IPO shareholder plans to reduce its stake by up to 67.05 million shares, representing no more than 1% of the total share capital [15] - Qinchuan Machine Tool's subsidiary plans to increase its registered capital from 50 million yuan to 200 million yuan, introducing new investors [17] Group 5 - Guiyang Bank's proposed director, Yu Rui, has resigned due to work reasons [19] - Guiyang Bank plans to acquire Xifeng Development Village Bank and establish a branch [20] - Aojing Medical's directors and executives plan to collectively reduce their stake by up to 25.28 million shares, accounting for no more than 0.19% of the total share capital [21] Group 6 - Zhongji Xuchuang intends to issue H-shares and list on the Hong Kong Stock Exchange [22] - ST Huatuo's stock will have its risk warning lifted, changing its name to Shiji Huatuo [25] - *ST Gaohong's stock has been delisted from the Shenzhen Stock Exchange [27] Group 7 - Tianwo Technology plans to publicly transfer a 7.12% stake in Qinghai Haihe Railway Transportation Co., with an assessed value of approximately 8.54 million yuan [28] - Xingye Technology's major shareholder plans to reduce its stake by up to 886.65 million shares, representing no more than 3% of the total share capital [29] - Jiangnan Chemical has successfully acquired 100% equity of Chongqing Shun'an Explosive Materials Co., with a transfer base price of 1 billion yuan [31]

Group 1 - The major shareholder, Fujian Chunhong Equity Investment Partnership (Limited Partnership), plans to reduce its stake in the company by up to 8.8665 million shares, which represents 3% of the company's total share capital [1]

Core Viewpoint - The major shareholder of Xingye Leather Technology Co., Ltd. plans to reduce its stake by up to 3% of the total share capital within three months, which may exert short-term pressure on the stock price [1][4]. Group 1: Reduction Plan Details - The shareholder, Fujian Chunhong Equity Investment Partnership, currently holds 31,464,000 shares, representing 10.65% of the total share capital [2]. - The reduction will be executed through a combination of centralized bidding and block trading, with a maximum of 8,866,500 shares to be sold, equating to 3% of the total share capital [2]. - The reduction period is set to begin approximately from early December 2025 to the end of February 2026, with the selling price determined by market conditions [2]. Group 2: Shareholder Background - Chunhong Investment is an action-in-concert party with the controlling shareholder and holds shares acquired prior to the company's initial public offering in May 2012 [3]. - The shareholder had previously committed not to transfer these shares for 36 months post-IPO, a commitment that has now been fulfilled [3]. - The reduction will not affect the commitments of the company's directors and supervisors regarding share transfers [3]. Group 3: Market Impact - The primary reason for the reduction is stated as "funding needs," which is considered a normal investment exit behavior [4]. - Despite the reduction not changing control, the market may perceive the sale as a cash-out, potentially leading to short-term stock price pressure [4]. - The timing, quantity, and price of the reduction remain uncertain and will depend on market conditions [4]. Group 4: Compliance and Regulatory Aspects - The reduction plan complies with relevant laws and regulations, and there are no prohibitive circumstances for the shareholder to reduce their stake [5]. - The company's board has verified the accuracy and completeness of the information disclosed [5]. - The company will fulfill its disclosure obligations regarding the implementation of the reduction plan as required by regulators [5].